Actionable news
0
All posts from Actionable news
Actionable news in AZN: ASTRAZENECA PLC,

Morgan Stanley's Berens Highlights Greater Payor Pushback For Relypsa's Veltassa

Invest with Confidence. Are you a financial professional? Stay on top of your portfolio with Benzinga Pro's real-time newsfeed and alerts and never miss a headline again.
Don't miss the chance to try it FREE today.

RLYP, Astrazeneca PLC NYSE:AZN - Morgan Stanley's Berens Highlights Greater Payor Pushback For Relypsa's Veltassa

Morgan Stanley’s AlphaWise survey revealed that awareness and current treatment patterns remained significant headwinds for Veltassa, the lead product of Relypsa Inc RLYP 7.34%. Morgan Stanley’s Andrew S. Berens maintains an Underweight rating for the company, with a price target of $9, saying that Veltessa faced significant commercialization...


More